No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
142 |
4. Check minimum number of eventsNone |
142 |
5. Include endpointsNone |
142 |
6. Filter based on genotype QC (FinnGen only) |
135 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of rectum
based on the number of shared cases.
Similar with more cases:
- Colorectal neuroendocrine tumor and carcinoma
- Colorectal cancer
- Colorectal cancer, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 135 | 73 | 62 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 58.20 | 55.99 | 60.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 138
- Matched controls
- 1380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
+∞
151.3
116
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
33.3
95.6
76
49
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
29.0
70.1
53
29
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
33.7
31
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
66.4
24.1
27
5
130
Kela drug reimbursment
Malignant tumour
+∞
23.6
22
*
UJF32
NOMESCO Finland
Coloscopy
5.6
22.8
71
220
UJF30
NOMESCO Finland
Ileoscopy through colon
7.2
20.9
37
67
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
18.1
17
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
15.9
15
*
H02AB02
ATC
dexamethasone; systemic
51.3
15.5
18
*
K62.1
ICD-10 Finland
Rectal polyp
48.1
14.5
17
*
L01BC06
ATC
capecitabine; oral
+∞
13.8
13
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.8
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.7
12
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
12.7
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
12.5
37
104
L01AX03
ATC
temozolomide; systemic
+∞
11.6
11
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
11.6
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
130.4
11.6
12
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.4
11.2
70
323
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
5.5
10.9
23
48
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.4
10.7
23
49
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
9.5
9
*
8249/3-C20.9
ICD-O-3
Neuroendocrine tumor, grade 2 of rectum, NOS
+∞
9.5
9
*
A04AA01
ATC
ondansetron; systemic, rectal
12.8
8.3
14
12
JN4AD
NOMESCO Finland
Body CT examination
4.8
8.0
19
44
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.0
7.7
14
14
JN4BD
NOMESCO Finland
Extensive body CT
6.7
7.7
19
32
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
3.0
7.5
42
176
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
7.4
55
268
8246/3-C20.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of rectum, NOS
+∞
7.4
7
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
7.4
7
*
H01CB02
ATC
octreotide; parenteral
+∞
7.4
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.4
7
*
WF002
NOMESCO Finland
Radical radiotherapy
42.2
6.8
8
*
UJG02
NOMESCO Finland
Proctoscopy
10.8
6.7
12
12
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.5
6.6
17
42
N02AA05
ATC
oxycodone; systemic
3.2
6.3
29
107
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
6.3
6
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
6.3
6
*
TJF80
NOMESCO Finland
Ostomy education
+∞
6.3
6
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
72
6.17
17.25
4.3
1.5
18.80
2.75
ug/l
0.49
29
54
92
490
3.63
11.86
7.2
3.5
35.44
36.22
g/l
0.66
87
460
95
635
2.59
6.30
13.3
5.5
4.09
4.22
e9/l
0.20
80
547
64
391
2.19
4.79
6.7
2.0
2.37
2.35
mmol/l
0.44
59
343
82
563
2.12
4.44
9.0
6.1
1.22
1.21
mmol/l
0.40
69
493
43
237
2.18
4.06
5.5
2.0
2.46
2.43
mmol/l
1.09
38
204
18
69
2.85
3.64
1.8
1.3
—
—
—
0
0
44
257
2.05
3.52
2.5
1.9
—
—
—
0
0
112
910
2.22
3.40
4.3
4.5
14.77
11.74
mm/h
0.84
104
846
53
336
1.94
3.34
3.8
2.8
0.19
0.41
e6/l
1.16
39
237
8
15
5.59
3.24
3.4
1.5
2.86
249.42
u/ml
—
8
15
22
102
2.38
3.07
3.7
3.1
—
—
—
0
0
21
97
2.37
2.95
4.6
5.6
9.02
8.91
mmol/l
0.02
21
92
130
1168
2.95
2.86
21.5
13.0
19.30
22.38
mg/l
0.76
115
932
70
506
1.78
2.79
2.7
2.3
—
—
estimate
—
0
0
84
644
1.78
2.71
3.1
3.4
0.00
0.00
estimate
-0.00
19
114
82
628
1.75
2.62
3.2
3.3
0.00
0.00
estimate
-0.00
19
125
82
636
1.71
2.43
3.2
3.4
0.00
0.00
estimate
-0.00
20
128
128
1150
2.56
2.25
22.7
12.8
81.60
79.25
ml/min/173m2
0.75
122
1059
27
156
1.91
2.16
7.3
7.2
103.52
104.35
mmol/l
0.62
27
156
5
11
4.67
1.96
1.8
1.3
—
—
—
0
0
73
579
1.55
1.77
2.5
2.0
91.65
97.90
pmol/l
0.44
44
271
11
48
2.40
1.75
4.6
1.1
2.55
2.82
g/l
0.65
11
43
8
31
2.68
1.69
1.4
1.3
—
—
—
0
0
29
187
1.70
1.63
4.2
2.7
1.66
2.73
e6/l
0.33
16
73
11
50
2.30
1.61
4.6
1.1
4.18
4.26
g/l
0.14
11
45
11
50
2.30
1.61
4.6
1.1
6.80
7.61
g/l
1.15
11
45
11
50
2.30
1.61
4.6
1.1
3.30
3.68
g/l
0.72
11
45
69
550
1.51
1.58
3.4
2.4
74.18
79.09
nmol/l
0.76
64
491
0
43
0.00
1.55
0.0
1.3
—
9.69
—
0
12
29
190
1.67
1.54
1.7
1.7
1294.95
1221.74
nmol/l
0.14
21
144
16
87
1.95
1.53
2.4
2.0
77.60
62.79
ml/min/173m2
—
5
34
30
203
1.61
1.40
4.0
2.5
0.52
1.07
e6/l
1.29
17
89
9
41
2.28
1.40
4.9
1.1
9.03
10.50
g/l
—
9
36
10
47
2.22
1.37
2.9
1.6
—
—
—
0
0
9
44
2.12
1.29
5.2
1.1
1.60
0.00
g/l
—
9
38
8
38
2.17
1.20
1.0
1.5
—
—
—
0
0
6
26
2.37
1.20
1.2
1.2
—
—
—
0
0
46
356
1.44
1.15
3.7
3.5
0.00
0.00
estimate
-0.00
19
115
107
965
1.48
1.12
28.8
16.0
14.25
13.51
%
4.40
107
955
7
34
2.11
1.04
1.1
1.2
—
—
—
0
0
5
22
2.32
1.04
1.6
1.2
—
—
—
0
0
7
35
2.05
1.01
1.1
1.2
—
—
—
0
0
9
51
1.82
0.96
1.6
1.4
—
—
—
0
0
7
37
1.94
0.95
6.0
1.1
0.00
0.00
g/l
—
7
31
6
27
2.28
0.94
1.8
1.2
—
—
—
0
0
51
418
1.35
0.89
4.4
2.8
746.93
1091.51
ng/l
0.77
38
348
32
243
1.41
0.88
1.9
1.8
469.36
423.29
pmol/l
0.65
25
194
20
140
1.50
0.82
8.1
8.0
5.25
5.14
kpa
0.22
20
134
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
17
117
1.52
0.76
8.9
8.8
112.18
123.53
g/l
1.89
17
117
56
476
1.30
0.74
3.6
3.2
0.00
0.00
estimate
-0.00
17
101
5
25
2.04
0.73
1.0
2.0
—
—
—
0
0
5
26
1.96
0.71
1.4
1.2
—
—
—
0
0
23
172
1.40
0.69
1.3
1.5
—
—
—
0
0
24
182
1.39
0.67
1.7
1.5
—
—
—
0
0
7
44
1.62
0.66
1.4
1.9
183.14
376.07
ug/l
—
7
39
15
104
1.50
0.65
1.6
2.7
13.37
15.07
nmol/l
0.31
15
96
118
1119
1.38
0.61
6.0
5.1
1.93
1.93
mu/l
0.00
111
1020
34
278
1.30
0.59
1.4
1.6
1.71
1.15
mg/l
0.50
27
222
124
1187
1.44
0.58
5.8
5.3
6.17
6.02
mmol/l
0.66
116
1093
122
1165
1.41
0.58
7.6
6.9
40.80
39.80
mmol/mol
0.51
114
1101
12
84
1.47
0.51
1.5
1.5
—
23.98
—
0
10
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
6.14
—
0
7
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
1.23
—
0
8
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
123
1192
1.29
0.36
5.2
5.4
1.44
1.48
mmol/l
0.55
113
1103
54
491
1.16
0.34
4.7
4.2
2.54
7.96
mg/mmol
2.40
32
304
125
1216
1.30
0.33
6.2
6.4
2.55
2.66
mmol/l
0.60
116
1126
32
281
1.18
0.30
1.4
1.3
0.46
0.83
u/ml
—
8
76
39
349
1.16
0.29
3.0
2.8
0.00
0.00
estimate
-0.00
15
98
123
1198
1.25
0.28
5.5
5.6
4.51
4.60
mmol/l
0.37
114
1113
97
929
1.15
0.27
5.2
4.0
14.97
14.71
pmol/l
0.44
91
839
8
67
1.21
0.27
2.0
2.4
0.89
1.32
%
—
8
67
5
71
0.69
0.27
1.4
1.5
—
—
—
0
0
6
82
0.72
0.25
1.5
2.5
—
—
—
0
0
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
1.01
—
0
7
0
13
0.00
0.21
0.0
1.5
—
0.92
—
0
7
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
0.97
—
0
7
0
14
0.00
0.20
0.0
1.5
—
1.88
—
0
8
117
1144
1.15
0.18
4.5
4.6
1.36
1.29
mmol/l
0.57
108
1053
21
186
1.15
0.18
1.4
1.7
—
—
—
0
0
7
60
1.18
0.18
2.0
1.4
—
—
—
0
0
5
69
0.71
0.17
1.2
1.0
—
—
—
0
0
20
224
0.87
0.17
1.4
1.3
1.17
12.65
u/ml
—
9
76
17
150
1.15
0.15
7.1
5.6
—
—
—
0
0
101
986
1.09
0.13
30.7
16.6
329.91
332.51
g/l
1.80
101
981
53
507
1.07
0.11
4.7
3.5
20.08
37.26
ng/l
1.71
42
358
67
648
1.07
0.10
2.6
2.8
—
—
—
0
0
5
46
1.09
0.09
1.6
1.8
3.26
2.41
mg/l
—
5
31
30
283
1.08
0.09
4.0
3.2
1.02
1.02
kg/l
0.06
20
180
54
555
0.96
0.06
2.1
2.0
1.40
1.35
mmol/l
0.17
45
461
27
262
1.04
0.02
3.8
3.9
1102.33
196.90
ng/l
0.38
21
217
10
106
0.94
0.01
1.8
1.4
—
—
—
0
0
35
344
1.02
0.00
3.8
3.8
24.31
25.65
%
0.15
20
162
25
249
1.00
0.00
2.6
3.0
0.53
0.78
ug/l
2.20
18
158
14
137
1.02
0.00
1.3
1.7
—
—
—
0
0
15
145
1.04
0.00
1.3
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.1
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
25.51
—
0
8
0
6
0.00
-0.00
0.0
3.2
—
68.67
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.8
—
717.83
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTUM_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of rectum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).